Ergoteles’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58,600	Closed	-$81.5K	–	307
2023 Q2	$81.5K	Buy	+58,600	New	+$81.5K	﹤0.01%	929
2021 Q4	–	Sell	-48,200	Closed	-$581K	–	1330
2021 Q3	$581K	Buy	+48,200	New	+$581K	0.02%	524